These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14750212)

  • 1. Modulation of DNA hypomethylation as a surrogate endpoint biomarker for chemoprevention of colon cancer.
    Tao L; Wang W; Kramer PM; Lubet RA; Steele VE; Pereira MA
    Mol Carcinog; 2004 Feb; 39(2):79-84. PubMed ID: 14750212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors.
    Pereira MA; Tao L; Wang W; Li Y; Umar A; Steele VE; Lubet RA
    Carcinogenesis; 2004 Oct; 25(10):1917-23. PubMed ID: 15205357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention: mouse colon and lung tumor bioassay and modulation of DNA methylation as a biomarker.
    Pereira MA; Tao LH; Wang W; Gunning WT; Lubet R
    Exp Lung Res; 2005 Mar; 31(2):145-63. PubMed ID: 15824018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents.
    Tao L; Kramer PM; Wang W; Yang S; Lubet RA; Steele VE; Pereira MA
    Carcinogenesis; 2002 Sep; 23(9):1447-54. PubMed ID: 12189186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
    Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV
    Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
    Pereira MA
    Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials.
    Einspahr JG; Alberts DS; Gapstur SM; Bostick RM; Emerson SS; Gerner EW
    Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):37-48. PubMed ID: 8993796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA hypomethylation induced by non-genotoxic carcinogens in mouse and rat colon.
    Pereira MA; Wang W; Kramer PM; Tao L
    Cancer Lett; 2004 Aug; 212(2):145-51. PubMed ID: 15279894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats.
    Dolara P; Luceri C; De Filippo C; Femia AP; Giovannelli L; Caderni G; Cecchini C; Silvi S; Orpianesi C; Cresci A
    Mutat Res; 2005 Dec; 591(1-2):237-46. PubMed ID: 16293270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of recommendations for colonic biomarker studies of candidate chemopreventive compounds in phase II clinical trials.
    Lipkin M
    J Cell Biochem Suppl; 1994; 19():94-8. PubMed ID: 7823612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin).
    Volate SR; Davenport DM; Muga SJ; Wargovich MJ
    Carcinogenesis; 2005 Aug; 26(8):1450-6. PubMed ID: 15831530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis.
    Lamy V; Roussi S; Chaabi M; Gossé F; Schall N; Lobstein A; Raul F
    Carcinogenesis; 2007 Jul; 28(7):1575-81. PubMed ID: 17434926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surrogate end-point biomarkers in chemopreventive drug development.
    Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
    IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
    Reddy BS
    Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
    Kelloff GJ; Sigman CC; Johnson KM; Boone CW; Greenwald P; Crowell JA; Hawk ET; Doody LA
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):127-37. PubMed ID: 10698472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis.
    Kwon Y; Magnuson BA
    Scand J Gastroenterol; 2007 Jan; 42(1):72-80. PubMed ID: 17190766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer chemoprevention: clinical development of aspirin as a chemopreventive agent.
    Krishnan K; Ruffin MT; Brenner DE
    J Cell Biochem Suppl; 1997; 28-29():148-58. PubMed ID: 9589361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Egg yolk proteins suppress azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colon of rats.
    Ishikawa S; Asano T; Takenoshita S; Nozawa Y; Arihara K; Itoh M
    Nutr Res; 2009 Jan; 29(1):64-9. PubMed ID: 19185779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci.
    Ziliotto L; Barbisan LF; Rodrigues MA
    Hum Exp Toxicol; 2008 Jun; 27(6):505-11. PubMed ID: 18784204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced genomic 5-methylcytosine content in human colonic neoplasia.
    Feinberg AP; Gehrke CW; Kuo KC; Ehrlich M
    Cancer Res; 1988 Mar; 48(5):1159-61. PubMed ID: 3342396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.